Additionally, the GeparQuinto study reported interactions between VEGFA SNPs and hormone receptor status, while our study indicated associations between VEGFA SNPs and ductal carcinoma, and FGF2 SNPs and receptor status. The gene discussed is FGF2; the disease is breast ductal adenocarcinoma.